Marketable Equity Securities (Details Narrative) - USD ($) $ in Thousands	12 Months Ended
Dec. 31, 2016	May 02, 2016	Dec. 31, 2015
Notes to Financial Statements
Shares of Vendetta purchased		7,240,000
Aggregagte consideration for shares of Vendetta; purchase cost of shares of 186,000; purchase cost of warrants 103,000	$ 735	$ 289
Gain on derivative instruments related to Vendetta Warrants	$ 629

The fair value as of the balance sheet date of firm holdings in corporate stocks (common and preferred), stock options, warrants and any other financial instrument which represents, or provides the ability to obtain, ownership rights in a corporation. Includes both pledged (to counterparties as collateral for financing transactions) and unpledged holdings.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 320
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35711157&loc=d3e42546-110969

Name:	us-gaap_FinancialInstrumentsOwnedCorporateEquitiesAtFairValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant